336 related articles for article (PubMed ID: 15770639)
1. Langerhans cell histiocytosis in neonates.
Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
3. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
4. Hungarian experience with Langerhans cell histiocytosis in childhood.
Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
[TBL] [Abstract][Full Text] [Related]
5. [Experiences with Langerhans' cell histiocytosis in children in Hungary].
Müller J; Koós R; Garami M; Hauser P; Borgulya G; Schuler D; Benyó G; Magyarosy E; Galántai I; Milei K; Török K; Bárdi E; Hunyadi K; Gábor K; Masáth P; Bodnár L; Kovács G
Magy Onkol; 2004; 48(4):289-95. PubMed ID: 15655573
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Langerhans cell histiocytosis in children: a population-based study.
Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
[TBL] [Abstract][Full Text] [Related]
7. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
[TBL] [Abstract][Full Text] [Related]
8. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry.
Minkov M; Steiner M; Pötschger U; Aricò M; Braier J; Donadieu J; Grois N; Henter JI; Janka G; McClain K; Weitzman S; Windebank K; Ladisch S; Gadner H;
J Pediatr; 2008 Nov; 153(5):700-5, 705.e1-2. PubMed ID: 18589441
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Langerhans cell histiocytosis in children under one year.
Lau L; Krafchik B; Trebo MM; Weitzman S
Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
[TBL] [Abstract][Full Text] [Related]
10. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998.
Alston RD; Tatevossian RG; McNally RJ; Kelsey A; Birch JM; Eden TO
Pediatr Blood Cancer; 2007 May; 48(5):555-60. PubMed ID: 16652350
[TBL] [Abstract][Full Text] [Related]
11. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
[TBL] [Abstract][Full Text] [Related]
12. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis.
Chikwava KR; Hunt JL; Mantha GS; Murphy JE; Jaffe R
Pediatr Dev Pathol; 2007; 10(1):18-24. PubMed ID: 17378622
[TBL] [Abstract][Full Text] [Related]
13. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
14. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms.
Battistella M; Fraitag S; Teillac DH; Brousse N; de Prost Y; Bodemer C
Arch Dermatol; 2010 Feb; 146(2):149-56. PubMed ID: 20157025
[TBL] [Abstract][Full Text] [Related]
15. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
16. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
[TBL] [Abstract][Full Text] [Related]
17. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome in children with Langerhans cell histiocytosis.
Jubran RF; Marachelian A; Dorey F; Malogolowkin M
Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
[TBL] [Abstract][Full Text] [Related]
19. Fetal and neonatal histiocytoses.
Isaacs H
Pediatr Blood Cancer; 2006 Aug; 47(2):123-9. PubMed ID: 16416419
[TBL] [Abstract][Full Text] [Related]
20. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
